Pharmacotherapy: A Pathophysiologic Approach

Foreword
Preface
Contributors
Guiding Principles of Pharmacotherapy
Sect. 1 Basic Concepts
1 Pharmacoeconomics: Principles
2 Health Outcomes and Quality of Life
3 Clinical Pharmacokinetics and Pharmacodynamics
4 Pediatrics
5 Geriatrics
6 Pharmacoepidemiology
7 Clinical Toxicology
Sect. 2 Cardiovascular Disorders
8 Cardiovascular Testing
9 Cardiopulmonary Resuscitation
10 Hypertension
11 Heart Failure
12 Ischemic Heart Disease
13 Myocardial Infarction
14 Arrhythmias
15 Cardiomyopathies
16 Cardiac Transplantation
17 Thromboembolic Disorders
18 Stroke
19 Hyperlipidemia
20 Peripheral Vascular Disease
21 Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock
22 Hypovolemic Shock
Sect. 3 Respiratory Disorders
23 Pulmonary Function Testing
24 Asthma
25 Chronic Obstructive Lung Disease
26 Respiratory Distress Syndrome
27 Drug-Induced Pulmonary Diseases
28 Cystic Fibrosis
Sect. 4 Gastrointestinal Disorders
29 Evaluation of the Gastrointestinal Tract
30 Gastroesophageal Reflux Disease
31 Peptic Ulcer Disease
32 Inflammatory Bowel Disease
33 Nausea and Vomiting
34 Diarrhea and Constipation
35 Portal Hypertension and Cirrhosis
36 Drug-Induced Liver Disease
37 Pancreatitis
38 Viral Hepatitis
39 Liver Transplantation
Sect. 5 Renal Disorders
40 Assessment of Renal Function
41 Acute Renal Failure
42 Chronic Renal Insufficiency and End-Stage Renal Disease
43 Renal Transplantation
44 Hemodialysis and Peritoneal Dialysis
45 Drug-Induced Renal Disease
46 Glomerulonephritis
47 Drug Therapy Individualization for Patients with Renal Insufficiency
48 Electrolyte Homeostasis
49 Acid-Base Disorders
Sect. 6 Neurologic Disorders
50 Evaluation of Neurologic Illness
51 Multiple Sclerosis
52 Epilepsy
53 Status Epilepticus
54 Acute Management of the Head Injury Patient
55 Parkinson's Disease
56 Pain Management
57 Headache Disorders: Migraine and Cluster
Sect. 7 Psychiatric Disorders
58 Evaluation of Psychiatric Illness
59 Childhood Disorders
60 Eating Disorders
61 Alzheimer's Disease
62 Substance-Related Disorders: Overview and Depressants, Stimulants, and Hallucinogens
63 Substance-Related Disorders: Alcohol, Nicotine, and Caffeine
64 Schizophrenia
65 Depressive Disorders
66 Bipolar Disorder
67 Anxiety Disorders
68 Obsessive-Compulsive Disorder
69 Sleep Disorders
Sect. 8 Endocrinologic Disorders
70 Diabetes Mellitus
71 Thyroid Disorders
72 Adrenal Gland Disorders
73 Pituitary Gland Disorders
Sect. 9 Gynecologic and Obstetric Disorders
74 Pregnancy and Lactation: Therapeutic Considerations
75 Infertility
76 Contraception
77 Menstrual-Related Disorders
78 Hormone Replacement Therapy
Sect. 10 Immunologic Disorders
79 Function and Evaluation of the Immune System
80 Systemic Lupus Erythematosus and Other Collagen Vascular Diseases
81 Allergic and Pseudoallergic Drug Reactions
Sect. 11 Bone and Joint Disorders
82 Osteoporosis and Osteomalacia
83 Rheumatoid Arthritis
84 Osteoarthritis
85 Gout and Hyperuricemia
Sect. 12 Disorders of the Eyes, Ears, Nose and Throat
86 Glaucoma
87 Allergic Rhinitis
Sect. 13 Dermatologic Disorders
88 Acne and Psoriasis
89 Drug-Induced Skin Reactions
Sect. 14 Hematologic Disorders
90 Hematopoiesis
91 Anemias
92 Coagulation Disorders
93 Sickle Cell Anemia
94 Drug-Induced Hematologic Disorders
Sect. 15 Infectious Diseases
95 Laboratory Tests to Direct Antimicrobial Pharmacotherapy
96 Antimicrobial Regimen Selection
97 Central Nervous System Infections
98 Lower Respiratory Tract Infections
99 Upper Respiratory Tract Infections
100 Skin and Soft Tissue Infections